Long-term treatment outcome in patients undergoing cricohyoidoepiglottopexy for glottic carcinoma / 中华耳鼻咽喉头颈外科杂志
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
;
(12): 825-829, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-322458
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the long-term results of cricohyoidoepiglottopexy(CHEP) in the treatment of glottic carcinoma.</p><p><b>METHODS</b>A retrospective chart review of 92 consecutive patients who underwent CHEP in the selected institut from January 1990 to December 2008. Of the 92 cases, 41 cases of stage I, 39 cases of stage II, 12 cases of stage III. The time for the decannulation and the removal of the nasal feeding and quality of phonation were used for evaluating postoperative functional rehabilitation. The estimated long-term survival rates were calculated by Kaplan-Meier method.</p><p><b>RESULTS</b>Among 92 patients, 26 cases (27 sides) received neck dissection and lymph nodes were pathologically positive in 3 patients (11.1%). All final surgical margins were negative for tumor invasion. Seven patients had postoperative radiotherapy and one had chemoradiation. Thirteen patients (14.1%) were found local recurrence and nine patients (9.8%) had postoperative metastases. Overall 3-, 5- and 10-year survival rates were 90.0%, 84.5% and 67.0% respectively. Cox multivariate analysis showed that the recurrence had significant influences on the overall survival rate.</p><p><b>CONCLUSION</b>CHEP not only is relatively easy to master, but also effective in the treatment of glottic carcinoma.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
General Surgery
/
Otorhinolaryngologic Surgical Procedures
/
Carcinoma, Squamous Cell
/
Laryngeal Neoplasms
/
Retrospective Studies
/
Treatment Outcome
/
Cricoid Cartilage
/
Epiglottis
/
Glottis
Type of study:
Observational study
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS